What's Happening?
The National Institutes of Health (NIH) Office of Research on Women’s Health (ORWH) has issued a Request for Information (RFI) to develop standardized Menopause Common Data Elements (CDEs). This initiative, outlined in notice NOT-OD-26-111, aims to harmonize
data collection across studies related to midlife women's health. The RFI seeks feedback from a broad range of stakeholders, including biomedical researchers, clinical trialists, biostatisticians, data stewards, healthcare professionals, and patient advocates, with a deadline for submissions by December 18, 2026. The goal is to create a unified repository of data definitions, clinical questions, and response sets to overcome current inconsistencies in documenting menopausal status, symptoms, and interventions. This fragmentation has historically hindered cross-study analysis and data reuse. The proposed CDEs are structured into three tiers: Core CDEs for universal collection, Supplemental CDEs for in-depth studies, and Exploratory CDEs for emerging measures. The NIH also specifically requests input on documenting premature ovarian insufficiency, early menopause, and medically induced menopause.
Why It's Important?
This NIH initiative is crucial for advancing women's health research by addressing long-standing data inconsistencies that have limited comprehensive understanding of menopause. Standardized CDEs will enable more robust cross-study pooling, meta-analyses, and secondary data reuse, leading to more reliable research findings. This will directly impact the development of more effective diagnostic tools, treatments, and interventions for conditions associated with menopause, such as cardiovascular risk, metabolic health, cognitive function, and bone density. For researchers, adopting these CDEs will streamline protocol design, data dictionary creation, and compliance with the NIH Data Management and Sharing (DMS) Policy, which emphasizes FAIR data principles (findability, accessibility, interoperability, and reusability). This standardization will also facilitate better integration of research data with electronic health records, ultimately improving the quality and impact of studies on a significant portion of the U.S. population.
What's Next?
Following the December 18, 2026, deadline for public comments, the NIH Office of Research on Women’s Health will review and synthesize the community input. This feedback will be instrumental in establishing the definitive national collection of Menopause Common Data Elements. Research administrators, clinical trial offices, and principal investigators are encouraged to actively participate in the public comment process, auditing their current women's health study templates to identify non-standard variables that will require alignment with the forthcoming NIH standards. It is anticipated that the finalized Menopause CDEs will be referenced in future NIH Notices of Funding Opportunity (NOFOs), making early familiarity a strategic advantage for grant applicants. The implementation of these standardized elements will likely lead to a more cohesive and impactful research landscape for midlife women's health in the United States.
Beyond the Headlines
The standardization of menopause data collection extends beyond mere technical harmonization; it represents a significant step towards rectifying historical underrepresentation and fragmentation in women's health research. By creating a common language for data, the NIH is fostering an environment where the unique health challenges faced by women during midlife can be more thoroughly investigated and understood. This initiative could lead to a paradigm shift in how menopause is studied, moving from disparate, siloed efforts to a more integrated and collaborative approach. The emphasis on capturing underrepresented clinical contexts, such as premature ovarian insufficiency, highlights a commitment to inclusivity and addressing health disparities. Ultimately, this effort has the potential to elevate the scientific rigor and clinical relevance of research, leading to more personalized and effective healthcare strategies for women across the nation.
